F 0624
Prepare residents for a safe transfer or discharge from the nursing home.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, record review, interviews, photographic evidence and review of policy and
procedures, the facility failed to ensure correct medications were provided upon discharge. This affected
one (#272) of six residents(#273, #274, #275, #276 and #277) reviewed for discharge planning.
Residents Affected - Few
Findings include:
Review of the closed medical record review for Resident #272 revealed an admission date of 11/17/23 and
a discharge to home date of 12/02/23. Diagnoses included but were not limited to osteoarthritis, cognitive
communication deficit, glaucoma, dysphagia, type II diabetes mellitus, hypertension, and depression.
Review of the 11/24/23 admission Minimum Data Set (MDS) 3.0 assessment revealed a Brief Interview of
Mental Status (BIMS) score of 12 which suggested Resident #272 had moderate cognitive impairment.
Review of the physicians' orders dated 12/02/23 for Resident #272 revealed she was receiving the following
medications upon discharge:
Acetaminophen 325 milligram (mg) every six hours as needed give two tablets
Amlodipine (used to treat high blood pressure and chest pain) 10 mg once a day
Aspirin 81 mg once a day
Bupropion HCl (antidepressant) 300 mg tablet once a day
Cholecalciferol 25 (vitamin D3) microgram (mcg) twice daily
Coenzyme Q10 (antioxidant) 200 mg once a day
Cyanocobalamin (vitamin B12) 1000 mcg once a day
Diclofenac sodium gel (nonsteroidal anti-inflammatory) one percent (%) 2 grams apply to lower back every
six hours as needed.
Docusate sodium (for constipation) 100 mg once a day
Doxazosin (used to treat high blood pressure) 2 mg once a day
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
365287
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365287
B. Wing
(X3) DATE SURVEY
COMPLETED
A. Building
12/28/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Cuyahoga Falls Ctr for Rehab & Nursin
2728 Bailey Rd
Cuyahoga Falls, OH 44221
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0624
Hydroxyzine HCl (used to treat anxiety) 25 mg every six hours as needed both eyes once a day.
Level of Harm - Minimal harm
or potential for actual harm
Lantanoprost drops (used to treat glaucoma) 0.005%; apply one drop to both eyes once daily.
Levothyroxine (thyroid medication) 137 mcg once a day
Residents Affected - Few
Loratadine (antihistamine) 10 mg once a day
Lumigan drops (used to treat glaucoma) 0.01% administer one drop once a day.
Maxzide tablet (diuretic) 75-50 mg administer half a tablet once a day.
Metformin (anti-diabetic medication) 500 mg twice a day
Metoprolol tartrate 50 mg tablet twice a day
Nystatin powder (antifungal) 100,000 unit/gram three times a day as needed topically.
Pantoprazole delayed release tablet (used to treat gastric reflux) 40 mg twice a day.
PreserVision AREDS-2 capsule 250-90-40-1 mg one tablet once daily.
Refresh Optive drops 0.5-0.9% administer one drop to both eyes every 12 hours as needed.
Saline Nasal Mist aerosol spray 0.65% one spray every 12 hours as needed.
Systane gel drops 0.4-0.3% administer one strip once a day.
Valsartan (used to treat high blood pressure) 320 mg once a day
Phone interview on 12/27/23 at 11:46 A.M. with Registered Nurse (RN) #508 revealed he had completed
the discharge assessment and discharge instructions with Resident #272 and was unaware any wrong
medications had been sent home with her.
Phone interview on 12/27/23 at 11:54 A.M. with Resident #272's son revealed his mother had contacted
him related to other residents' medications being sent home with her at discharge. Resident #272's son
stated he had photographic evidence of medications belonging to other residents that were sent home with
Resident #272.
Observation of the four photographs (jpeg numbers: #163932, #163942, #163947 and #163926) revealed
medication punch cards containing a 30-day supply of medications which belonged to Residents #275,
#276 and #277 which were sent home with Resident #272. These medications included Gabapentin
(anticonvulsant and nerve medication) 100 mg, Gabapentin 300 mg, Gabapentin 600 mg and
Methocarbamol (muscle relaxant) 500 mg.
Review of the October 2016 facility policy called Discharge Planning revealed the facility would determine
the resident's preferred pharmacy. Nursing was to review the medication and treatment list with the
physician prior to discharge. Nursing was to arrange for resident medication or prescription to be provided
upon discharge. The policy stated to refer to Medication Provided to Discharge
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365287
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365287
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/28/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Cuyahoga Falls Ctr for Rehab & Nursin
2728 Bailey Rd
Cuyahoga Falls, OH 44221
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0624
Resident in the Nursing Policies.
Level of Harm - Minimal harm
or potential for actual harm
Interview on 12/27/23 at 12:40 P.M. with the Director of Nursing (DON) and Regional Nurse Consultant
#502 confirmed the facility policy titled Discharge Planning indicated to refer to Medication Provided to
Discharge Resident in Nursing Policies; however, the facility did not have a specific policy for medications at
discharge. When a skilled resident was sent home, they were sent with their medications and could be in
the original bubble medication card packaging obtained from the facility pharmacy.
Residents Affected - Few
Phone interview on 12/27/23 at 1:15 P.M. with former Resident #272 revealed she was alert to person,
place, time, and situation. Further interview revealed Resident #272 received medications for three facility
residents in addition to her own medications. Resident #272 said she did not take the medications and
alerted the home health nurse of her concern.
Three attempts to contact the home health nurse were unsuccessful.
Interview on 12/28/23 at 10:07 A.M. with the DON revealed she was unsure how the additional medications
were sent home with Resident #272 at discharge. Observation of the medication cart, at the time of the
interview, revealed all drugs were stored in locked compartments and were labeled in accordance with
professional standards including the resident's name, medication name, dosage, and directions.
This deficiency represents non-compliance investigated under Complaint Number OH00148961.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365287
If continuation sheet
Page 3 of 3